LYB

Insights on LyondellBasell Industries NV – What Our Analysts Know

Large-cap Industrials company LyondellBasell Industries NV has moved -0.6% so far today on a volume of 69,215, compared to its average of 1,764,777. In contrast, the S&P 500 index moved 0.0%.

LyondellBasell Industries NV trades -9.03% away from its average analyst target price of $101.33 per share. The 21 analysts following the stock have set target prices ranging from $85.0 to $115.0, and on average have given LyondellBasell Industries NV a rating of hold.

Anyone interested in buying LYB should be aware of the facts below:

  • LyondellBasell Industries NV's current price is 15.5% above its Graham number of $79.82, which implies that at its current valuation it does not offer a margin of safety

  • LyondellBasell Industries NV has moved 2.7% over the last year, and the S&P 500 logged a change of 21.6%

  • Based on its trailing earnings per share of 6.99, LyondellBasell Industries NV has a trailing 12 month Price to Earnings (P/E) ratio of 13.2 while the S&P 500 average is 15.97

  • LYB has a forward P/E ratio of 10.0 based on its forward 12 month price to earnings (EPS) of $9.26 per share

  • The company has a price to earnings growth (PEG) ratio of -3.36 — a number near or below 1 signifying that LyondellBasell Industries NV is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 2.26 compared to its sector average of 4.06

  • LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally.

  • Based in Houston, the company has 19,300 full time employees and a market cap of $29.9 Billion. LyondellBasell Industries NV currently returns an annual dividend yield of 5.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS